21-应何时为妇女检测人乳头状瘤病毒.pdf
http://www.100md.com
第1页 |
参见附件(45kb)。
述评
参考文献
1 Mer ck News room. Mer ck′ s inve st igat ional vacc ine GARDASI LTM pre vented
100 per cent of cervic al pre -ca ncers and non- invas ive c ervica l canc ers
as sociated with HPV types 16 a nd 18 in ne w cl inical s tudy. P res s relea se 6 Oct
2005. ( a cce ssed 17 Oc t 2005) .
2 Wor ld He al th Orga nizat ion. WHO c onsultat ion on human pa pil lomavi rus
vacc ine s . Wkly Epidemiol Rec 2005 ; 80: 299-301.
3 Koutsky LA, Aul t KA, Whe ele r CM, Brown DR , Ba rr E , Alvar ez FB , et al .
A cont rol led t rial of huma n pa pil lomavi rus type 16 vacc ine . N Engl J Med
2002; 347 : 1645-51.
4 Harper DM, Fra nco EL, Whee ler C, F erris DG, Jenkins D, Sc huind A, et
al . Effica cy of a bivalent L1 vi rus -l ike part ic le va ccine in pre vent ion of
infect ion wi th hum an pa pi l lomavi rus type s 16 a nd 18 in young women: a
randomized c ontr ol le d t ria l . La ncet 2004 ; 364: 1757-65.
5 Vi lla LL, Cos ta R LR , Pe tta CA, Andr ade R P , Aul t KA, Giuliano AR , et al .
Prophylac tic quadrivalent human papil lomavirus ( types 6, 11, 16, a nd 18 )
L1 vi rus -l ike par ticle vacc ine in young wome n: a randomized double -bl ind
plac ebo- cont rol led mul t ic entr e phase II efficac y tr ia l . La ncet Oncol 2005; 6:
271-8.
6 Bosch F X, Lorinc z A, Munoz N, Mei je r CJ , Sha h KV. The c ausal re lat ion
be twe en huma n papi l lomavi rus and cervic al ca nc er . J Cl in P a thol 2002; 55:
244-65.
7 Munoz N, Bosch FX, de Sanjose S , H erre ro R , Cas tel lsague X, Sha h KV, et
al . Epidemiologic clas si fic ation of human papi lloma vi rus type s a s sociate d with
cervic al ca ncer . N Engl J Med 2003; 348: 518 -27 .
8 Parkin DM, Bra y F, F erlay J , P isa ni P . Global c ancer stat ist ics , 2002. CA
Cancer J Cl in 2005 ; 55: 74-108.
9 Cli ffor d GM, Ga llus S, Herre ro R , Munoz N, Snijders PJF , Vacca rel la S , et
al . Worldwide dis tr ibut ion of huma n papi lloma vi rus types in c ytological ly
normal women in the I nter na tional Age ncy for R esearc h on Cancer HPV
pr eva lenc e surveys : a pooled a nalys is . La ncet 2005; 366: 991 -8.
10 P eto J , Gi lham C, F le tc he r O, Mat the ws FE . The cer vic al ca ncer epidemic
that sc reening has pre vented in the UK. Lancet 2004; 364: 249-56.
11 NHS Ce rvical Ca ncer Scre ening P rogramme . Cervica l ca ncer - incidence,morta li ty a nd risk fa ctors. ( acc es se d 17 Oct 2005 ) .
12 UK Col labora tive Group for HIV and STI Sur vei llanc e. F ocus on prevent ion.
HIV a nd other sexua l ly tr a nsmit ted infect ions in the United Kingdom in 2003.
London: Hea l th Pr otect ion Agency Cent re for Infect ions , 2004. ( a cces sed 17
Oct 2005 ) .
13 Johnson AM, Mercer CH, Erens R , Copa s AJ , McMa nus S, Well ings K, et a l .
Sexua l beha viour in Bri tain: pa rtnerships, pra ct ices , a nd HIV risk beha viours.
Lance t 2001; 358: 1835 -42 .
14 Internat iona l F ina nce F a cil i ty for Immunisa tion. New I nterna tiona l F ina nce
F aci li ty for Immunisa t ion Could Sa ve 10 Mi l lion Lives. P ress relea se 9 Sep
2005. ( a cces sed 17 Oct 2005) .
BMJ 2005; 331 : 915-6
应何时为妇女检测人乳头瘤病毒
该病毒检测用于宫颈癌筛查前景良好, 但仍需慎重
When to test women for human papillomavirus
Cervical screening using HPV testing shows great promise but warrants caution
由于人们对人乳头瘤病毒( HPV) 以及宫颈癌
病因的深入认识, 使预防策略成为可能 ......
参考文献
1 Mer ck News room. Mer ck′ s inve st igat ional vacc ine GARDASI LTM pre vented
100 per cent of cervic al pre -ca ncers and non- invas ive c ervica l canc ers
as sociated with HPV types 16 a nd 18 in ne w cl inical s tudy. P res s relea se 6 Oct
2005. ( a cce ssed 17 Oc t 2005) .
2 Wor ld He al th Orga nizat ion. WHO c onsultat ion on human pa pil lomavi rus
vacc ine s . Wkly Epidemiol Rec 2005 ; 80: 299-301.
3 Koutsky LA, Aul t KA, Whe ele r CM, Brown DR , Ba rr E , Alvar ez FB , et al .
A cont rol led t rial of huma n pa pil lomavi rus type 16 vacc ine . N Engl J Med
2002; 347 : 1645-51.
4 Harper DM, Fra nco EL, Whee ler C, F erris DG, Jenkins D, Sc huind A, et
al . Effica cy of a bivalent L1 vi rus -l ike part ic le va ccine in pre vent ion of
infect ion wi th hum an pa pi l lomavi rus type s 16 a nd 18 in young women: a
randomized c ontr ol le d t ria l . La ncet 2004 ; 364: 1757-65.
5 Vi lla LL, Cos ta R LR , Pe tta CA, Andr ade R P , Aul t KA, Giuliano AR , et al .
Prophylac tic quadrivalent human papil lomavirus ( types 6, 11, 16, a nd 18 )
L1 vi rus -l ike par ticle vacc ine in young wome n: a randomized double -bl ind
plac ebo- cont rol led mul t ic entr e phase II efficac y tr ia l . La ncet Oncol 2005; 6:
271-8.
6 Bosch F X, Lorinc z A, Munoz N, Mei je r CJ , Sha h KV. The c ausal re lat ion
be twe en huma n papi l lomavi rus and cervic al ca nc er . J Cl in P a thol 2002; 55:
244-65.
7 Munoz N, Bosch FX, de Sanjose S , H erre ro R , Cas tel lsague X, Sha h KV, et
al . Epidemiologic clas si fic ation of human papi lloma vi rus type s a s sociate d with
cervic al ca ncer . N Engl J Med 2003; 348: 518 -27 .
8 Parkin DM, Bra y F, F erlay J , P isa ni P . Global c ancer stat ist ics , 2002. CA
Cancer J Cl in 2005 ; 55: 74-108.
9 Cli ffor d GM, Ga llus S, Herre ro R , Munoz N, Snijders PJF , Vacca rel la S , et
al . Worldwide dis tr ibut ion of huma n papi lloma vi rus types in c ytological ly
normal women in the I nter na tional Age ncy for R esearc h on Cancer HPV
pr eva lenc e surveys : a pooled a nalys is . La ncet 2005; 366: 991 -8.
10 P eto J , Gi lham C, F le tc he r O, Mat the ws FE . The cer vic al ca ncer epidemic
that sc reening has pre vented in the UK. Lancet 2004; 364: 249-56.
11 NHS Ce rvical Ca ncer Scre ening P rogramme . Cervica l ca ncer - incidence,morta li ty a nd risk fa ctors. ( acc es se d 17 Oct 2005 ) .
12 UK Col labora tive Group for HIV and STI Sur vei llanc e. F ocus on prevent ion.
HIV a nd other sexua l ly tr a nsmit ted infect ions in the United Kingdom in 2003.
London: Hea l th Pr otect ion Agency Cent re for Infect ions , 2004. ( a cces sed 17
Oct 2005 ) .
13 Johnson AM, Mercer CH, Erens R , Copa s AJ , McMa nus S, Well ings K, et a l .
Sexua l beha viour in Bri tain: pa rtnerships, pra ct ices , a nd HIV risk beha viours.
Lance t 2001; 358: 1835 -42 .
14 Internat iona l F ina nce F a cil i ty for Immunisa tion. New I nterna tiona l F ina nce
F aci li ty for Immunisa t ion Could Sa ve 10 Mi l lion Lives. P ress relea se 9 Sep
2005. ( a cces sed 17 Oct 2005) .
BMJ 2005; 331 : 915-6
应何时为妇女检测人乳头瘤病毒
该病毒检测用于宫颈癌筛查前景良好, 但仍需慎重
When to test women for human papillomavirus
Cervical screening using HPV testing shows great promise but warrants caution
由于人们对人乳头瘤病毒( HPV) 以及宫颈癌
病因的深入认识, 使预防策略成为可能 ......
您现在查看是摘要介绍页,详见PDF附件(45KB,2页)。